Mohammad RM - Search Results

1

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.

Khan HY, Nagasaka M, Li Y, Aboukameel A, Uddin MH, Sexton R, Bannoura S, Mzannar Y, Al-Hallak MN, Kim S, Beydoun R, Landesman Y, Mamdani H, Uprety D, Philip PA, Mohammad RM, Shields AF, Azmi AS. Khan HY, et al. Among authors: mohammad rm. Cancer Res Commun. 2022 May;2(5):342-352. doi: 10.1158/2767-9764.crc-21-0176. Epub 2022 May 10. Cancer Res Commun. 2022. PMID: 35573474 Free PMC article.

2

Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.

Mohammad RM, al-Katib A, Pettit GR, Sensenbrenner LL. Mohammad RM, et al. Cancer Res. 1994 Jan 1;54(1):165-8. Cancer Res. 1994. PMID: 8261437

3

Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.

Li Y, Mohammad RM, al-Katib A, Varterasian ML, Chen B. Li Y, et al. Among authors: mohammad rm. Leuk Res. 1997 May;21(5):391-7. doi: 10.1016/s0145-2126(96)00078-1. Leuk Res. 1997. PMID: 9225065

4

Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.

Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Pancreas. 1998 Jan;16(1):19-25. doi: 10.1097/00006676-199801000-00004. Pancreas. 1998. PMID: 9436858

5

Induction of apoptosis in breast cancer cells by TPA.

Li Y, Bhuiyan M, Mohammad RM, Sarkar FH. Li Y, et al. Among authors: mohammad rm. Oncogene. 1998 Dec 3;17(22):2915-20. doi: 10.1038/sj.onc.1202218. Oncogene. 1998. PMID: 9879997

6

Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.

Merati K, said Siadaty M, Andea A, Sarkar F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V, Grignon DJ, Adsay NV. Merati K, et al. Am J Clin Oncol. 2001 Oct;24(5):447-52. doi: 10.1097/00000421-200110000-00007. Am J Clin Oncol. 2001. PMID: 11586094

7

Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.

Mohammad RM, Adsay NV, Philip PA, Pettit GR, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Anticancer Drugs. 2001 Oct;12(9):735-40. doi: 10.1097/00001813-200110000-00005. Anticancer Drugs. 2001. PMID: 11593055

8

Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.

Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Mohammad R, et al. Clin Cancer Res. 2002 Apr;8(4):1277-83. Clin Cancer Res. 2002. PMID: 11948143

9

Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.

Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM. Nabha SM, et al. Among authors: mohammad rm. Clin Cancer Res. 2002 Aug;8(8):2735-41. Clin Cancer Res. 2002. PMID: 12171907

10

Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.

Mohammad RM, Aboukameel A, Nabha S, Ibrahim D, Al-Katib A. Mohammad RM, et al. J Drug Target. 2002 Aug;10(5):405-10. doi: 10.1080/1061186021000001850. J Drug Target. 2002. PMID: 12442811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page